Post by
enriquesuave on Nov 29, 2021 6:18pm
Awesome results! New Gold Standard Coming IMHO
94-100% CR potential. Out of 11 PH2 patients with evaluable data at 90 days, 8 are CR, 2 are PR ( have potential to become CR if cancer is from UTUC) and 1 is NR ( patient who passed away but had a negative cytology at 30 days which is 95% indicative of CR status at that time point). If we add 2 optimized treated patients from PH1 we get
10 out of 13 CR, 2 PR , and one NR. 7 patients still pending data have not yet reached 90 days time point.. Good that they treated 6 more anther 5-10 for Accelerated FDA approval IMO if they keep this up.. So for the 5 newly evaluable patients, 4 were CR and 1 was PR which are added to the 6 from last Quarterly for a total of 11 PH2 patients.
Comment by
Pandora on Nov 29, 2021 7:00pm
Also, on the vaccine front at this time apparently it is still too early: "This research and development is currently ongoing and no reportable data is available at this time."
Comment by
silverT on Nov 29, 2021 7:04pm
That sounds dam good .....I think a while back one of our doc's said 20% would be great
Comment by
99942Apophis on Nov 29, 2021 7:13pm
We all have been waiting for them to blow the the doors off with this next set of numbers, in my biased opinion it will happen.
Comment by
Eoganacht on Nov 29, 2021 7:17pm
Just fantastic! The potential CR of 75% for all 33 patients who have received a full dose, includes the 12 who were undertreated! And there are still 70 more patients coming who will receive the optimized dose!